1225 Human T Cell Development from Marrow Precursor Cells in NOD/SCID hu Mice Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene TherapyS398 ������� �[.]
Trang 1Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
S398
! =
J
"6
"6
1223 Intracerebral Grafting of Hematopoietic Stem
Cells Genetically Modified by the VSV
Cells Genetically Modified by the VSV-G Pseudo-T -G Pseudo-T -G Pseudo-Type ype
Retroviral V
Retroviral Vector GCDNsap as a New Gene and Cellular ector GCDNsap as a New Gene and Cellular
Therapy for Neurological Disorders
Masafumi Onodera, 1 Takeru Shimizu, 2, 3 Shin Kaneko, 1 Hideki
Mochizuki, 4 Toshiro Nagasawa, 1 Hiromitsu Nakauchi 2.3
1 Hematology, Institute of Clinical Medicine/ Univ Tsukuba,
Tsukuba, Ibaraki, Japan; 2 Immunology, Institute of Basic
Medicine/ Univ Tsukuba, Tsukuba, Ibaraki, Japan; 3 CREST/JST,
Tsukuba, Ibaraki, Japan; 4 Neurology, Juntendo University School
Medicine, Tokyo, Tokyo, Japan.
"% A J ("8 J D "
1224 Studies on the Stem Cell Plasticity of Mouse
Bone Marrow
Zong-Yi Li, 1 Daniel Stone, 1 Shaoheng Ni, 1 Fernando Camargo, 2
Thalia Papayannopoulou, 1 George Stamatoyannopoulos, 1 Andre
Lieber 1
1 Medical Genetics, University of Washington, Seattle, WA, United
States; 2 Center for Cell and Gene Therapy, Baylor College of
Medicine, Houston, Tex, United States.
1225 Human T Cell Development from Marrow Precursor Cells in NOD/SCID-hu Mice
Michael W Melkus, Joel Gatlin, Miguel Islas, Angela Padgett-Thomas, J Victor Garcia.
1 Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, United States.
J
J
Trang 2Molecular Therapy Vol 5, No 5, May 2002, Part 2 of 2 Parts
" " "
1226 The Developmental Potential of a Single Adult
Hematopoietic Stem Cell
Fernando D Camargo, 1 Margaret A Goodell 1
1 Program in Cell and Molecular Biology and Center for Cell and
Gene Therapy, Baylor College of Medicine, Houston, TX, United
States.
" " "
1227 Effect of Neutralizing Antibodies on Adenovirus
Gene Delivery by the Intravenous Route of
Administration: T
Administration: Translational Model for Human Immune ranslational Model for Human Immune
Response to Adenovirus
Van Tsai, 1 Amena Rahman, 2 Drake LaFace, 1 Monica Zepeda, 1 Shu
Fen Wen, 1 Robert Ralston, 1 Dan Maneval 1
1 Canji Inc, San Diego, CA, United States; 2 GenStar Therapeutics,
San Diego, CA, United States.
1228 Characterization and Modulation of the Undesirable T Cell-Mediated Responses to T Undesirable T Cell-Mediated Responses to Transgenes ransgenes
Maria-Grazia Roncarolo, 1 Megan K Levings, 1 Patrizia Mangia, 2 Claudio Bordignon, 1,2 Sarah Marktel, 1 Chiara Bonini, 2 Catia Traversari 2,3
1 San Raffaele Telethon Institute for Gene Therapy, Scientific Institute H San Raffaele, Milan, Italy; 2 Cancer Immunotherapy and Gene Therapy Program, Scientific Institute H San Raffaele, Milan, Italy; 3 MolMed SpA, Scientific Institute H San Raffaele, Milan, Italy.
1229 Control of Graft-V
1229 Control of Graft-Versus-Host Disease Using a ersus-Host Disease Using a Chimeric Suicide Gene
Michael P Rettig, Julie K Ritchey, John F DiPersio.